Table 2

Baseline patient characteristics

CharacteristicValue
Age (years)63 ± 7
Sex (male)5 (29%)
Body mass index28 ± 4
Atrial fibrillation pattern
 Paroxysmal13 (77%)
 Persistent3 (23%)
AF duration (months)21 ± 19
Arterial hypertension8 (50%)
Obstructive sleep apnoea3 (18%)
Diabetes mellitus5 (29%)
LVEF (%)58 ± 6
LA AP diameter (mm)43 ± 4
LA volume (mL)111 ± 24
CharacteristicValue
Age (years)63 ± 7
Sex (male)5 (29%)
Body mass index28 ± 4
Atrial fibrillation pattern
 Paroxysmal13 (77%)
 Persistent3 (23%)
AF duration (months)21 ± 19
Arterial hypertension8 (50%)
Obstructive sleep apnoea3 (18%)
Diabetes mellitus5 (29%)
LVEF (%)58 ± 6
LA AP diameter (mm)43 ± 4
LA volume (mL)111 ± 24

Data are presented as mean ± SD or N (%).

AF, atrial fibrillation; AP, anteroposterior; LA, left atrium; LVEF, left ventricular ejection fraction.

Table 2

Baseline patient characteristics

CharacteristicValue
Age (years)63 ± 7
Sex (male)5 (29%)
Body mass index28 ± 4
Atrial fibrillation pattern
 Paroxysmal13 (77%)
 Persistent3 (23%)
AF duration (months)21 ± 19
Arterial hypertension8 (50%)
Obstructive sleep apnoea3 (18%)
Diabetes mellitus5 (29%)
LVEF (%)58 ± 6
LA AP diameter (mm)43 ± 4
LA volume (mL)111 ± 24
CharacteristicValue
Age (years)63 ± 7
Sex (male)5 (29%)
Body mass index28 ± 4
Atrial fibrillation pattern
 Paroxysmal13 (77%)
 Persistent3 (23%)
AF duration (months)21 ± 19
Arterial hypertension8 (50%)
Obstructive sleep apnoea3 (18%)
Diabetes mellitus5 (29%)
LVEF (%)58 ± 6
LA AP diameter (mm)43 ± 4
LA volume (mL)111 ± 24

Data are presented as mean ± SD or N (%).

AF, atrial fibrillation; AP, anteroposterior; LA, left atrium; LVEF, left ventricular ejection fraction.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close